##FILTER=off-target=Variant marked as 'off-target'.
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##SAMPLE=<ID=NA12878_03,Gender=n/a,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Other diseases,DiseaseStatus=affected>
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=mmsplice splice variant effect: max. delta_logit_psi score (logit scale of variant's effect on the exon inclusion, positive score shows higher exon inclusion, negative higher excusion rate - a score beyond 2, -2 can be considered strong)
##DESCRIPTION=MMSplice_pathogenicity=mmsplice splice variant effect: max. pathogenicity score (probability of the pathogenic effect of the variant)
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	6526183	6526183	G	A	hom		QUAL=3484;DP=113;AF=1.00;MQM=60	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::	TNFRSF25:NM_001039664.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_001042663.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265592.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1468C>T::,TNFRSF25:NM_003790.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:NM_020631.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:NM_148965.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148966.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148967.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148970.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_198681.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::	regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive/Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive];	297904 [benign DISEASE=Distal spinal muscular atrophy];			rs3007417	0.2023	0.1843	1065,.	0.5020,0.0510,0.0004,0.0703,0.0791	-0.6580			0.06,0.14	9.16			gain/donor/6526182-6526183/Medium/3.418541			-0.1011	0.9103	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	10460485	10460485	T	C	het		QUAL=769;DP=79;AF=0.47;MQM=60	PGD	synonymous	PGD:ENST00000270776:synonymous_variant:LOW:exon3/13:c.120T>C:p.Asp40=:PF03446 [NAD binding domain of 6-phosphogluconate dehydrogenase],PGD:ENST00000538557:synonymous_variant:LOW:exon3/13:c.81T>C:p.Asp27=:PF03446 [NAD binding domain of 6-phosphogluconate dehydrogenase],PGD:ENST00000541529:synonymous_variant:LOW:exon3/12:c.120T>C:p.Asp40=:PF03446 [NAD binding domain of 6-phosphogluconate dehydrogenase]	PGD:NM_001304451.2:synonymous_variant:LOW:exon3/12:c.120T>C:p.Asp40=:,PGD:NM_001304452.2:synonymous_variant:LOW:exon3/13:c.81T>C:p.Asp27=:,PGD:NM_002631.4:synonymous_variant:LOW:exon3/13:c.120T>C:p.Asp40=:	regulatory_region_variant:promoter					rs1049887	0.2338	0.2812	1065,.	0.0912,0.3481,0.2880,0.2977,0.2369	0.5280			0.68,0.90	13.09						0.0963	0.277	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PGD (inh=n/a oe_syn=1.11 oe_mis=0.77 oe_lof=0.11)
chr1	11856378	11856378	G	A	het		QUAL=2227;DP=162;MQM=60	MTHFR	missense	MTHFR:ENST00000376583:missense_variant:MODERATE:exon5/12:c.788C>T:p.Ala263Val:PF02219 [Methylenetetrahydrofolate reductase],MTHFR:ENST00000376585:missense_variant:MODERATE:exon6/13:c.788C>T:p.Ala263Val:PF02219 [Methylenetetrahydrofolate reductase],MTHFR:ENST00000376590:missense_variant:MODERATE:exon5/12:c.665C>T:p.Ala222Val:PF02219 [Methylenetetrahydrofolate reductase],MTHFR:ENST00000376592:missense_variant:MODERATE:exon4/11:c.665C>T:p.Ala222Val:PF02219 [Methylenetetrahydrofolate reductase]	MTHFR:NM_001330358.1:missense_variant:MODERATE:exon5/12:c.788C>T:p.Ala263Val:,MTHFR:NM_005957.5:missense_variant:MODERATE:exon5/12:c.665C>T:p.Ala222Val:		607093 [GENE=MTHFR PHENOS=Vascular disease,susceptibility to/Schizophrenia,susceptibility to,181500,Autosomal dominant/Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Thromboembolism,susceptibility to,188050,Autosomal dominant];	3520 [drug response DISEASE=Venous thrombosis,Neoplasm of stomach,Gastrointestinal stromal tumor,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,MTHFR deficiency, thermolabile type,Neural tube defects, folate-sensitive,not specified,carboplatin response - Efficacy,cyclophosphamide response - Toxicity/ADR,methotrexate response - Dosage, Efficacy, Toxicity/ADR,not provided];	CM950819 [CLASS=DFP MUT=ALT PHEN="Cardiovascular disease association with" GENE=MTHFR];		rs1801133	0.2454	0.3149	1182,.	0.1076,0.5027,0.2905,0.3396,0.1451	9.0450	D(0.02),D(0.02),D(0.00),D(0.00)	D(0.99),D(0.99),D(0.94),D(0.94)	0.98,0.98	25.60	0.84					-0.1079	0.1025	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	31905889	31905889	-	CAG	hom		QUAL=7465;DP=238;AF=0.97;MQM=60	SERINC2	inframe_insertion	SERINC2:ENST00000373709:inframe_insertion:MODERATE:exon9/10:c.1102_1104dup:p.Gln368dup:PF03348 [Serine incorporator (Serinc)],SERINC2:ENST00000373710:inframe_insertion:MODERATE:exon10/11:c.1129_1131dup:p.Gln377dup:PF03348 [Serine incorporator (Serinc)],SERINC2:ENST00000536384:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:PF03348 [Serine incorporator (Serinc)],SERINC2:ENST00000536859:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:PF03348 [Serine incorporator (Serinc)]	SERINC2:NM_001199037.1:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:,SERINC2:NM_001199038.2:inframe_insertion:MODERATE:exon10/11:c.1129_1131dup:p.Gln377dup:,SERINC2:NM_001199039.2:inframe_insertion:MODERATE:exon10/11:c.937_939dup:p.Gln313dup:,SERINC2:NM_018565.3:inframe_insertion:MODERATE:exon9/10:c.1114_1116dup:p.Gln372dup:,SERINC2:NM_178865.5:inframe_insertion:MODERATE:exon9/10:c.1102_1104dup:p.Gln368dup:						rs3050461		0.8121	10040,.	0.6921,0.5481,0.5322,0.7034,0.5620					10.78						0.0426	0.3707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SERINC2 (inh=n/a oe_syn=1.08 oe_mis=1.04 oe_lof=0.87)
chr1	57422472	57422472	G	A	het		QUAL=2962;DP=205;AF=0.55;MQM=60	C8B	stop_gained	C8B:ENST00000371237:stop_gained:HIGH:exon3/12:c.361C>T:p.Arg121Ter:,C8B:ENST00000535057:stop_gained:HIGH:exon4/13:c.175C>T:p.Arg59Ter:,C8B:ENST00000543257:stop_gained:HIGH:exon4/13:c.205C>T:p.Arg69Ter:	C8B:NM_000066.4:stop_gained:HIGH:exon3/12:c.361C>T:p.Arg121Ter:,C8B:NM_001278543.1:stop_gained:HIGH:exon4/13:c.205C>T:p.Arg69Ter:,C8B:NM_001278544.1:stop_gained:HIGH:exon4/13:c.175C>T:p.Arg59Ter:		120960 [GENE=C8B PHENOS=C8 deficiency,type II,613789,Autosomal recessive];	35593 [pathogenic DISEASE=Type II complement component 8 deficiency];	CM952410 [CLASS=DM MUT=ALT PHEN="Complement C8b deficiency" GENE=C8B];		rs150022116		0.0001		0.0001,0.0001,0.0001,0.0002,0.0001	1.0610			0.29,0.98	42.00					COSV64776847	-0.1137	0.47	0	6	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	62740781	62740781	A	-	het	off-target	QUAL=265;DP=121;AF=20.55;MQM=60	KANK4	intron	KANK4:ENST00000354381:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:ENST00000371153:intron_variant:MODIFIER:intron2/9:c.17-22del::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron2/9:c.17-22del::						rs761923018		0.1206	0,.	0.0807,0.1653,0.1052,0.1096,0.1776	0.6420				10.51						0.1041	0.2513	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	120612003	120612004	GG	-	het		QUAL=3950;DP=2047;AF=0.20;MQM=48	NOTCH2	frameshift	NOTCH2:ENST00000256646:frameshift_variant:HIGH:exon1/34:c.17_18del:p.Pro6ArgfsTer27:	NOTCH2:NM_001200001.1:frameshift_variant:HIGH:exon1/22:c.17_18del:p.Pro6ArgfsTer27:,NOTCH2:NM_024408.4:frameshift_variant:HIGH:exon1/34:c.17_18del:p.Pro6ArgfsTer27:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	600275 [GENE=NOTCH2 PHENOS=Hajdu-Cheney syndrome,102500,Autosomal dominant/Alagille syndrome 2,610205,Autosomal dominant];	218795 [benign DISEASE=not specified];			rs372504208		0.1715	0,.	0.2029,0.1158,0.1100,0.2030,0.1594	0.6960				23.70						0.0822	0.0744	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"DX132253_01: wahrscheinlich durch Pseudogen"	NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	144206548	144206548	C	T	het	gene_blacklist	QUAL=3611;DP=400;AF=0.50;MQM=60	NBPF8	missense	NBPF8:ENST00000356801:missense_variant:MODERATE:exon19/24:c.131C>T:p.Thr44Ile:PF06758 [Repeat of unknown function (DUF1220)]	::intergenic_variant:MODIFIER::::						rs201297880		0.0000	0,.		0.8920	T(0.07)	B(0.24)	0.00,0.05	5.97	0.05				COSV63330388	-0.1455	0.1666	952	1189	0 / 0	2	"[2] auto-classification 14.09.2017  "			NBPF8 (inh=n/a oe_syn=1.65 oe_mis=2.47 oe_lof=2.16)
chr1	156565049	156565049	-	AC	hom		QUAL=6110;DP=216;AF=1.00;MQM=60	GPATCH4	frameshift	GPATCH4:ENST00000368232:frameshift_variant:HIGH:exon8/8:c.1068_1069insGT:p.Phe357ValfsTer91:,GPATCH4:ENST00000438976:frameshift_variant:HIGH:exon8/8:c.1083_1084insGT:p.Phe362ValfsTer?:	GPATCH4:NM_015590.3:frameshift_variant:HIGH:exon8/8:c.1083_1084insGT:p.Phe362ValfsTer91:,GPATCH4:NM_182679.2:frameshift_variant:HIGH:exon8/8:c.1068_1069insGT:p.Phe357ValfsTer91:						rs72559129		0.9986	15511,.	0.9819,0.9984,1.0000,1.0000,0.9999					22.10						-0.0064	0.8943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NAXE (inh=AR oe_syn=0.98 oe_mis=0.87 oe_lof=0.78), GPATCH4 (inh=n/a oe_syn=0.74 oe_mis=0.86 oe_lof=0.69)
chr1	171112490	171112490	C	T	hom		QUAL=870;DP=32;AF=0.97;MQM=60	FMO6P	stop_gained	FMO6P:ENST00000236166:stop_gained:HIGH:exon2/8:c.313C>T:p.Gln105Ter:PF00743 [Flavin-binding monooxygenase-like]	FMO6P:NR_002601.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.906-3127C>T::	regulatory_region_variant:promoter_flanking_region					rs1736565	0.6380	0.6104	6009,.	0.7708,0.6771,0.5953,0.5276,0.6085	0.2800			0.75,0.99	37.00						-0.2235	0.344	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FMO6P (inh=n/a oe_syn=0.78 oe_mis=0.80 oe_lof=0.63)
chr1	183191250	183191250	C	T	het		QUAL=1289;DP=109;AF=0.48;MQM=60	LAMC2	stop_gained	LAMC2:ENST00000264144:stop_gained:HIGH:exon6/23:c.667C>T:p.Arg223Ter:,LAMC2:ENST00000493293:stop_gained:HIGH:exon6/22:c.667C>T:p.Arg223Ter:	LAMC2:NM_005562.3:stop_gained:HIGH:exon6/23:c.667C>T:p.Arg223Ter:,LAMC2:NM_018891.3:stop_gained:HIGH:exon6/22:c.667C>T:p.Arg223Ter:		150292 [GENE=LAMC2 PHENOS=Epidermolysis bullosa,junctional,non-Herlitz type,226650,Autosomal recessive/Epidermolysis bullosa,junctional,Herlitz type,226700,Autosomal recessive];	188791 [likely pathogenic DISEASE=Junctional epidermolysis bullosa gravis of Herlitz];	CM043021 [CLASS=DM MUT=ALT PHEN="Epidermolysis bullosa junctional" GENE=LAMC2];		rs753268823		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.6350			0.26,0.97	36.00						-0.1626	0.3239	0	1	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr2	38301847	38301847	C	T	het		QUAL=4465;DP=321;AF=0.53;MQM=60	CYP1B1	missense	CYP1B1:ENST00000260630:missense_variant:MODERATE:exon2/3:c.685G>A:p.Glu229Lys:PF00067 [Cytochrome P450],CYP1B1:ENST00000407341:missense_variant:MODERATE:exon2/3:c.685G>A:p.Glu229Lys:PF00067 [Cytochrome P450]	CYP1B1:NM_000104.3:missense_variant:MODERATE:exon2/3:c.685G>A:p.Glu229Lys:	regulatory_region_variant:promoter	601771 [GENE=CYP1B1 PHENOS=Glaucoma 3A,primary open angle,congenital,juvenile,or adult onset,231300,Autosomal recessive/Anterior segment dysgenesis 6,multiple subtypes,617315];	68467 [uncertain significance(replaced by megSAP based on classifications:1x2,2x3) DISEASE=Congenital ocular coloboma,Irido-corneo-trabecular dysgenesis,Primary congenital glaucoma,Glaucoma 3, primary congenital, A,not provided];	CM014173 [CLASS=DM? MUT=ALT PHEN="Glaucoma primary congenital" GENE=CYP1B1];		rs57865060	0.0104	0.0109	1,.	0.0009,0.0019,0.0000,0.0080,0.0499	3.7110	D(0.01),D(0.01)	B(0.20),B(0.20)	0.80,0.97	25.00	0.40					-0.0419	0.0802	4	186	0 / 0	3	"[3] auto-classification 14.09.2017  "			CYP1B1 (inh=AR oe_syn=1.21 oe_mis=1.12 oe_lof=0.67), CYP1B1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	168041152	168041152	T	C	het	gene_blacklist	QUAL=717;DP=66;AF=0.48;MQM=60	XIRP2	intron,splice_donor	XIRP2:ENST00000295237:intron_variant:MODIFIER:intron2/9:c.563-26093T>C::,XIRP2:ENST00000409043:intron_variant:MODIFIER:intron3/9:c.563-26093T>C::,XIRP2:ENST00000409195:intron_variant:MODIFIER:intron3/10:c.563-26093T>C::,XIRP2:ENST00000409728:splice_donor_variant:HIGH:intron4/10:c.661+2T>C::,XIRP2:ENST00000409756:intron_variant:MODIFIER:intron2/8:c.563-26093T>C::,XIRP2:ENST00000420519:splice_donor_variant:HIGH:intron3/9:c.661+2T>C::	XIRP2:NM_001079810.3:intron_variant:MODIFIER:intron3/9:c.563-26093T>C::,XIRP2:NM_001199143.1:splice_donor_variant:HIGH:intron4/10:c.661+2T>C::,XIRP2:NM_152381.5:intron_variant:MODIFIER:intron3/10:c.563-26093T>C::					L1MEg1 (LINE/L1)	rs16853169	0.1026	0.0941	143,.	0.1344,0.0530,0.0822,0.0891,0.1642	-0.5410			0.01,0.15	11.43		3.89>-3.87		0.000/0.000		-2.4478	1.0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XIRP2 (inh=n/a oe_syn=1.08 oe_mis=1.16 oe_lof=0.78)
chr3	38645420	38645420	T	C	het		QUAL=3985;DP=361;AF=0.45;MQM=60	SCN5A	missense	SCN5A:ENST00000333535:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000413689:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000414099:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000423572:missense_variant:MODERATE:exon11/27:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000425664:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000443581:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000449557:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000450102:missense_variant:MODERATE:exon11/26:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000451551:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel],SCN5A:ENST00000455624:missense_variant:MODERATE:exon11/27:c.1673A>G:p.His558Arg:PF11933 [Cytoplasmic domain of voltage-gated Na+ ion channel]	SCN5A:NM_000335.4:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:,SCN5A:NM_001099404.1:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:,SCN5A:NM_001099405.1:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:,SCN5A:NM_001160160.2:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:,SCN5A:NM_001160161.1:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:,SCN5A:NM_001354701.2:missense_variant:MODERATE:exon12/27:c.1673A>G:p.His558Arg:,SCN5A:NM_198056.2:missense_variant:MODERATE:exon12/28:c.1673A>G:p.His558Arg:		600163 [GENE=SCN5A PHENOS=Atrial fibrillation,familial,10,614022,Autosomal dominant/Sick sinus syndrome 1,608567,Autosomal recessive/Sudden infant death syndrome,susceptibility to,272120,Autosomal recessive/Ventricular fibrillation,familial,1,603829/Long QT syndrome 3,603830,Autosomal dominant/Heart block,nonprogressive,113900,Autosomal dominant/Cardiomyopathy,dilated,1E,601154,Autosomal dominant/Brugada syndrome 1,601144,Autosomal dominant/Heart block,progressive,type IA,113900,Autosomal dominant];	48289 [benign/likely benign DISEASE=Arrhythmia,Sick sinus syndrome,Long QT syndrome,Romano-Ward syndrome,Paroxysmal familial ventricular fibrillation,Brugada syndrome,Brugada syndrome 1,not specified,Progressive familial heart block,Cardiovascular phenotype,Dilated Cardiomyopathy, Dominant,not provided]; 440849 [pathogenic DISEASE=Progressive familial heart block, type 1A];	CM031355 [CLASS=DFP MUT=ALT PHEN="Phenotype modifier association with" GENE=SCN5A];		rs1805124	0.2304	0.2451	972,.	0.2922,0.2158,0.0933,0.2301,0.2470	1.6570	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.02,0.93	9.48	0.29					0.0273	0.1404	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[3] ahschak1 02.05.2018 [1] ahharmf1 10.01.2019. 7355 x hom in gnomAD"			SCN5A (inh=AR+AD oe_syn=0.98 oe_mis=0.78 oe_lof=0.21)
chr3	142231062	142231062	-	A	het	off-target	QUAL=5;DP=31;AF=0.16;MQM=56	ATR	intron	ATR:ENST00000350721:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:ENST00000383101:intron_variant:MODIFIER:intron26/45:c.4660+39dup::	ATR:NM_001184.4:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron26/45:c.4660+39dup::		601215 [GENE=ATR PHENOS=Seckel syndrome 1,210600,Autosomal recessive/Cutaneous telangiectasia and cancer syndrome,familial,614564,Autosomal dominant];			(A)n (Simple_repeat)	rs74269486		0.4606	1984,.	0.1935,0.1566,0.1714,0.1151,0.0902					1.71						0.0114	0.3272	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr7	130297120	130297120	A	-	hom		QUAL=1215;DP=53;AF=0.92;MQM=60	COPG2	intron	COPG2:ENST00000445977:intron_variant:MODIFIER:intron7/8:c.493-11del::	COPG2:NM_001290033.1:intron_variant:MODIFIER:intron7/9:c.493-11del::,COPG2:NM_012133.6:intron_variant:MODIFIER:intron7/22:c.493-11del::						rs34699820		0.7969	9480,.	0.6814,0.6268,0.6545,0.7691,0.6562	0.0310				8.20						0.1705	0.0836	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COPG2 (inh=n/a oe_syn=1.16 oe_mis=0.75 oe_lof=0.41)
chr11	117772955	117772955	T	C	het		QUAL=2020;DP=173;AF=0.47;MQM=60	TMPRSS13	stop_retained	TMPRSS13:ENST00000524993:stop_retained_variant:LOW:exon13/13:c.1703A>G:p.Ter568=:,TMPRSS13:ENST00000528626:stop_retained_variant:LOW:exon12/12:c.1598A>G:p.Ter533=:	TMPRSS13:NM_001077263.3:stop_retained_variant:LOW:exon13/13:c.1703A>G:p.Ter568=:,TMPRSS13:NM_001206789.2:stop_retained_variant:LOW:exon12/12:c.1598A>G:p.Ter533=:						rs73020481	0.0615	0.0730	79,.	0.0695,0.0439,0.0055,0.0832,0.0568	0.2750			0.01,0.93	7.74						0.1631	0.8899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMPRSS13 (inh=n/a oe_syn=0.94 oe_mis=0.85 oe_lof=0.60)
chr12	6397417	6397417	C	G	het	off-target	QUAL=30;DP=361;AF=0.45;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region				L1M4 (LINE/L1)						0.1350			0.01,0.19	4.14								0	0	0 / 0					
chr12	11420422	11420484	CCTCCTTGTGGGGGTGGTCCTTCTGGCTTTCCTGGACGAGGTGGGGGACCTTGAGGTTTGTTG	-	hom		QUAL=337;DP=27;AF=0.96;MQM=54	PRB3	inframe_deletion,splice_acceptor&coding_sequence&intron	PRB3:ENST00000279573:inframe_deletion:MODERATE:exon3/4:c.699_761del:p.Lys235_Asn255del:PF15240 [Proline-rich],PRB3:ENST00000381842:splice_acceptor_variant&coding_sequence_variant&intron_variant:HIGH:exon4/6intron3/5:c.605-32_635del::,PRB3:ENST00000538488:splice_acceptor_variant&coding_sequence_variant&intron_variant:HIGH:exon5/7intron4/6:c.604+32_635del::	PRB3:NM_006249.5:intron_variant:MODIFIER:intron3/5:c.649+50_650-15del::						rs1565762655		0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0001	1.4710				17.07			loss/donor/11420444-11420443/Medium/1.949060&loss/acceptor/11420452-11420453/Medium/4.240418			-3.7028	1.0	2115	197	0 / 0	2	"[2] auto-classification 16.09.2017  "			PRB3 (inh=n/a oe_syn=1.11 oe_mis=1.21 oe_lof=0.79)
chr12	133264022	133264022	C	G	het		QUAL=30;DP=58;AF=0.43;MQM=60	PXMP2,POLE,RP13-672B3.2	upstream_gene	PXMP2:ENST00000317479:upstream_gene_variant:MODIFIER::::,POLE:ENST00000320574:upstream_gene_variant:MODIFIER::::,PXMP2:ENST00000428960:upstream_gene_variant:MODIFIER::::,POLE:ENST00000535270:upstream_gene_variant:MODIFIER::::,RP13-672B3.2:ENST00000537262:upstream_gene_variant:MODIFIER::::,PXMP2:ENST00000539093:upstream_gene_variant:MODIFIER::::,PXMP2:ENST00000543589:upstream_gene_variant:MODIFIER::::,PXMP2:ENST00000545677:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant										0.2600			0.03,0.13	6.94								0	1	0 / 0					POLE (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.52), PXMP2 (inh=n/a oe_syn=0.91 oe_mis=1.14 oe_lof=0.56)
chr15	43701947	43701947	A	-	het		QUAL=368;DP=58;AF=0.43;MQM=60	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000382044:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000450115:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TUBGCP4:NM_001286414.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron25/28:c.2426-8del::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TUBGCP4:NM_014444.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::						rs56813954		0.3535	751,.	0.1846,0.3650,0.4202,0.3555,0.3896	0.7510				8.12						-0.0467	0.0936	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr16	48329922	48329922	-	T	het		QUAL=297;DP=61;AF=0.33;MQM=60	LONP2	splice_region&intron	LONP2:ENST00000285737:splice_region_variant&intron_variant:LOW:intron8/14:c.1384-3dup::,LONP2:ENST00000535754:splice_region_variant&intron_variant:LOW:intron7/13:c.1252-3dup::	LONP2:NM_001300948.3:splice_region_variant&intron_variant:LOW:intron7/13:c.1252-3dup::,LONP2:NM_001348078.2:splice_region_variant&intron_variant:LOW:intron8/16:c.1384-3dup::,LONP2:NM_031490.5:splice_region_variant&intron_variant:LOW:intron8/14:c.1384-3dup::						rs766396809		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000					11.45						0.116	0.0247	0	0	0 / 0					LONP2 (inh=n/a oe_syn=0.89 oe_mis=0.71 oe_lof=1.04)
chr16	88921634	88921634	C	G	het		QUAL=520;DP=69;AF=0.39;MQM=60	GALNS	intron,splice_donor,3'UTR	GALNS:ENST00000268695:intron_variant:MODIFIER:intron1/13:c.120+1532G>C::,GALNS:ENST00000542788:splice_donor_variant:HIGH:intron2/12:c.94+1G>C::,GALNS:ENST00000568311:3_prime_UTR_variant:MODIFIER:exon3/3:c.*161G>C::	GALNS:NM_000512.5:intron_variant:MODIFIER:intron1/13:c.120+1532G>C::,GALNS:NM_001323543.2:intron_variant:MODIFIER:intron1/12:c.-312+1532G>C::,GALNS:NM_001323544.2:intron_variant:MODIFIER:intron1/14:c.-33+1532G>C::	regulatory_region_variant:promoter	612222 [GENE=GALNS PHENOS=Mucopolysaccharidosis IVA,253000,Autosomal recessive];	803281 [benign DISEASE=Mucopolysaccharidosis, MPS-IV-A];			rs34150867	0.4008	0.3784	2527,.	0.5918,0.2413,0.4532,0.2964,0.2367	-0.7040			0.00,0.04	1.05		5.51>-2.77	loss/donor/88921634-88921635/Medium/0.654905	0.000/0.000		-2.9316	1.0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALNS (inh=AR oe_syn=1.32 oe_mis=1.07 oe_lof=0.69), TRAPPC2L (inh=AR oe_syn=1.45 oe_mis=1.11 oe_lof=1.65)
chr17	41244936	41244936	G	A	het		QUAL=2131;DP=132;AF=0.58;MQM=60	BRCA1	missense,intron	BRCA1:ENST00000309486:missense_variant:MODERATE:exon9/22:c.1724C>T:p.Pro575Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000346315:missense_variant:MODERATE:exon10/19:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000351666:intron_variant:MODIFIER:intron6/18:c.548-1887C>T::,BRCA1:ENST00000352993:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000354071:missense_variant:MODERATE:exon10/18:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000357654:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000468300:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000471181:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000491747:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000493795:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:PF04873 [Ethylene insensitive 3],BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1825C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2789C>T::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Multifactorial,Autosomal dominant];	41812 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 1,not specified,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917		0.4842	4287,.	0.8253,0.3484,0.3789,0.3338,0.5316	4.2470	T(1.00),T(1.00), , ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	B(0.00),B(0.00), , ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	0.02,0.89	18.04	0.14				COSV58784386	-0.0116	0.5898	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chrX	93983960	93983960	G	T	hom		QUAL=2131;DP=132;AF=0.58;MQM=60		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					AluSx (SINE/Alu)	rs12216940	0.0056	0.0079	1,63		0.2310			0.01,0.10	2.93								6	5	0 / 0					
